Literature DB >> 18160154

Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance.

Ken McDonald1.   

Abstract

Diastolic heart failure (DHF) is now firmly established as a significant contributor to the heart failure syndrome. However, compared to the better studied systolic dysfunction heart failure relatively little is known about this form of the syndrome. Epidemiological data have demonstrated that it is particularly important in the elderly likely reflecting the combination of several changes occurring in the myocardium occurring with advancing years, including progressive fibrosis and stiffening of the myocardium, the impact of hypertension over the years and the increased likelihood of ischaemic heart disease. This review will focus on the relevant aetiological factors in DHF, possible pathophysiological mechanisms and outline new and evolving therapeutic strategies for this problem.

Entities:  

Mesh:

Year:  2007        PMID: 18160154     DOI: 10.1016/j.ijcard.2007.10.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Aging and heart failure: changing demographics and implications for therapy in the elderly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 2.  STEMI and heart failure in the elderly: role of adverse remodeling.

Authors:  Anwar Jelani; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 3.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 4.  Treatment for chronic heart failure in the elderly: current practice and problems.

Authors:  Pasquale Abete; Gianluca Testa; David Della-Morte; Gaetano Gargiulo; Gianluigi Galizia; Domenico de Santis; Antonio Magliocca; Claudia Basile; Francesco Cacciatore
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

5.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.

Authors:  Eva van Rooij; Lillian B Sutherland; Jeffrey E Thatcher; J Michael DiMaio; R Haris Naseem; William S Marshall; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

6.  Cardiorenal syndrome caused by heart failure with preserved ejection fraction.

Authors:  Chiara Lazzeri; Serafina Valente; Roberto Tarquini; Gian Franco Gensini
Journal:  Int J Nephrol       Date:  2011-02-07

7.  MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarction.

Authors:  Ying Lin; Vusumuzi Leroy Sibanda; Hong-Mei Zhang; Hui Hu; Hui Liu; An-Yuan Guo
Journal:  Sci Rep       Date:  2015-04-13       Impact factor: 4.379

Review 8.  New aspects in cardiorenal syndrome and HFpEF.

Authors:  Ana Belén Méndez; Maria Antonieta Azancot; Aleix Olivella; María José Soler
Journal:  Clin Kidney J       Date:  2022-05-06

Review 9.  Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection.

Authors:  Branislav Kura; Barbora Kalocayova; Yvan Devaux; Monika Bartekova
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.